Manganese(II)-Based Responsive Contrast Agent Detects Glucose-Stimulated Zinc Secretion from the Mouse Pancreas and Prostate by MRI

Inorg Chem. 2021 Feb 15;60(4):2168-2177. doi: 10.1021/acs.inorgchem.0c02688. Epub 2021 Jan 28.

Abstract

A Mn(II)-based zinc-sensitive MRI contrast agent, MnPyC3A-BPEN, was prepared, characterized, and applied in imaging experiments to detect glucose-stimulated zinc secretion (GSZS) from the mouse pancreas and prostate in vivo. Thermodynamic and kinetic stability tests showed that MnPyC3A-BPEN has superior kinetic inertness compared to GdDTPA, is less susceptible to transmetalation in the presence of excess Zn2+ ions, and less susceptible to transchelation by albumin. In comparison with other gadolinium-based zinc sensors bearing a single zinc binding moiety, MnPyC3A-BPEN appears to be a reliable alternative for imaging β-cell function in the pancreas and glucose-stimulated zinc secretion from the prostate.

MeSH terms

  • Animals
  • Contrast Media / chemistry*
  • Contrast Media / pharmacokinetics
  • Glucose / pharmacology
  • Magnetic Resonance Imaging / methods*
  • Male
  • Manganese / chemistry*
  • Mice
  • Pancreas / drug effects
  • Pancreas / metabolism*
  • Prostate / drug effects
  • Prostate / metabolism*
  • Tissue Distribution
  • Zinc / metabolism*

Substances

  • Contrast Media
  • Manganese
  • Glucose
  • Zinc